Inventor · disambiguated record
Paul William Glue
Also filed as: GLUE PAUL · GLUE PAUL W · GLUE PAUL WILLIAM
18 granted patents·12 pending applications·610 citations·filing 1997–2024
95Inventor score
Files withDOUGLAS PHARMACEUTICALS LTD12SCHERING CORP6FOSTER CAROLYN ANN3PFIZER2ATHENEX THERAPEUTICS LTD1
Top patents by PatentIndex Score
30 records- 0196US5908621APolyethylene glycol modified interferon therapySCHERING CORP·Filed 1997·Granted Jun 1, 1999·218 cites·4 claims
- 0295US10869838B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Dec 22, 2020·11 cites·32 claims
- 0395US10744094B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Aug 18, 2020·12 cites·13 claims
- 0495US10441544B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2017·Granted Oct 15, 2019·15 cites·11 claims
- 0595US6177074B1Polyethylene glycol modified interferon therapySCHERING CORP·Filed 1999·Granted Jan 23, 2001·161 cites·4 claims
- 0694US11045424B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Jun 29, 2021·9 cites·13 claims
- 0793US6524570B1Polyethylene glycol modified interferon therapySCHERING CORP·Filed 2000·Granted Feb 25, 2003·53 cites·36 claims
- 0890US12090123B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Granted Sep 17, 2024·3 cites·20 claims
- 0989US12128140B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Granted Oct 29, 2024·2 cites·66 claims
- 1088US11471416B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACETICALS LTD·Filed 2020·Granted Oct 18, 2022·4 cites·24 claims
- 1187US11471415B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2018·Granted Oct 18, 2022·6 cites·22 claims
- 1286US6849254B1HCV combination therapySCHERING CORP·Filed 2000·Granted Feb 1, 2005·49 cites·20 claims
- 1375US6262049B1Method of reducing nicotine and tobacco craving in mammalsSCHERING CORP·Filed 1998·Granted Jul 17, 2001·40 cites·6 claims
- 1474US12472146B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Nov 18, 2025·0 cites·22 claims
- 1573US12350378B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Jul 8, 2025·0 cites·21 claims
- 1669US12350379B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Jul 8, 2025·0 cites·23 claims
- 1764US2025049734A1Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1864US2023172926A1THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCERATHENEX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1961US6824768B2Ribavirin-pegylated interferon alfa induction HCV combination therapySCHERING CORP·Filed 1999·Granted Nov 30, 2004·27 cites·15 claims
- 2061US2009324542A1Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disordersFOSTER CAROLYN ANN·Filed 2009·Application pending·0 cites
- 2161US2024189259A2Extended Release Pharmaceutical FormulationDOUGLAS PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2255US2014271541A1Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disordersFOSTER CAROLYN ANN·Filed 2014·Application pending·0 cites
- 2355US2006052373A1Combination of dopamine agonists and aralkyl and aralkylidene heterocyclic lactams and imidesPFIZER·Filed 2004·Application pending·0 cites
- 2451US2012225031A1Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disordersFOSTER CAROLYN ANN·Filed 2012·Application pending·0 cites
- 2550US2006046979A1Organic compoundsFOSTER CAROLYN A·Filed 2003·Application pending·0 cites
- 2649US2001025038A1Method of reducing craving in mammalsFiled 2001·Application pending·0 cites
- 2747US7776851B2Use of neurokinin antagonists in the treatment of urinary incontinenceNOVARTIS AG·Filed 2004·Granted Aug 17, 2010·0 cites·2 claims
- 2846US2005250803A1Combination of dopamine agonists and monoamine reuptake inhibitorsPFIZER·Filed 2004·Application pending·0 cites
- 2939US2002182179A1HIV TherapyFiled 2000·Application pending·0 cites
- 3039US2018207148A1THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCERKINEX THERAPEUTICS HK LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul William Glue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →